Clinical therapy of schistosomiasis mansoni: the Brazilian contribution.
The review gives a detailed account of the history of drug development, treatment and drug resistance for clinical therapy of schistosomiasis mansoni, specially emphasizing the importance of Brazilian contribution on antischistosomal chemotherapy, as well as on the control of this parasitic disease.
Katz
N
N
Laboratório de Esquistossomose, Centro de Pesquisas René Rachou, Fiocruz. Av. Augusto de Lima 1715, CEP 30190-002 Belo Horizonte, MG, Brazil. nkatz@cpqrr.fiocruz.br
Coelho
P M Z
PM
D000818:Animals; D000871:Anthelmintics / Q000266:history* / Q000627:therapeutic use*; D001938:Brazil / Q000453:epidemiology; D004351:Drug Resistance; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D012550:Schistosoma mansoni / Q000187:drug effects; D012555:Schistosomiasis mansoni / Q000188:drug therapy* / Q000453:epidemiology / Q000266:history*
D000871:Anthelmintics